Do you want to learn more about ALS clinical trials and why some succeed and others fail? Register to attend the 2013 National Advocacy Day and Public Policy Conference to hear the latest news about ALS clinical trials.
In addition, our Chief Scientist, Lucie Bruijn, Ph.D., will be giving a presentation about The ALS Association's Translational Research Advancing Therapies for ALS (TREAT ALS™) Program which funds a diverse portfolio of research at leading institutions around the globe. Projects are selected through a peer review process and specifically focus on the most promising studies that we think have the highest potential to lead to treatments and a cure.
Please join us in Washington, D.C., this May to learn more about ALS Research and advance our legislative priorities on Capitol Hill. To learn more about the 2013 National ALS Advocacy Day and Public Policy Conference and to register, please go to our Website or contact the Public Policy Department at email@example.com.
We look forward to seeing you in May!